Professional Documents
Culture Documents
RECOMMENDATION
Former guidelines recommended starting Pap smear
screening at age 18 or the onset of sexual activity.
2006: initiation 3 years after the onset of sexual
activity or age 21, whichever comes first.
2009: cervical cancer screening begin at age 21,
regardless of sexual history.
This recommendation was confirmed in 2012 and
again in January 2016.[2]
TYPES
Parameters
ACS Recommendations
Screening after
hysterectomy
HPV-vaccinated
women
CONTRAINDICATION
Relative Contraindications for Pap
Testing: (Temporary Deferral):
Heavy menstrual bleeding
Women less than 8 weeks postpartum (vaginal delivery) or 8
weeks post-abortion.
Visible cervical mass with
bleedingrefer
PLEASE NOTE: Pap testing should
NOT be deferred if vaginal
discharge or signs and symptoms
of vaginal infection are present
TYPES
Testing for cervical cancer is
performed using either:
I. Liquid-Based Cytology or
II. Conventional (slide) Pap Test
(no difference in screening interval is
recommended).
Devices for
collecting cervical
cellular samples:
a)Aylesbury spatula
(modified Ayres
spatula) for sampling
the cervix and
transformation zone
b)Endocervical brush to
sample the
endocervix.
c)Cervical broom (LBC
PREPARATION
I. The patient should not
menstruating, schedule pap
smear between days 12-16
of menstrual cycle if possible
II. Avoid vaginal intercourse 1-2
days prior to smear
III. No douching or use of
tampons, use of medical
vaginal cream or
Example of Forms:
contraceptive cream for 24- 1)Borang
48 hours prior to cervical
Permohonan Pap
screening
Smear
PROCEDURE
1) Equipment:
Examination table with foot supports
Examination light
Metal or plastic speculum
Examination gloves
Cervical spatula (Aylesbury) and
cytobrush
Liquid-based cytology container or
glass slide and fixative
Plastic
speculum
Metal
speculum
3) Technique:
Squamocolumnar
junction
Manageme
nt
Unsatisfact
ory smear
Negative
For
Intraepithel
ial lesion or
malignancy
(NIIM)
Abnormal
pap smear
Abnormal
Pap Smear
and CIN in
Pregnancy
Squamous cell
abnormalities
Atypical
low-grade
Squamous
Intraepithelial
lesion (ISII)
Pap smear
guidelines
after
hysterecto
my
Glandular cell
Abnormalities
High-grade
Squamous
Intraepithelial
lesion (HSII) and
squamous cell
carcinoma
Atypical
glandular cell
and
adenocarcinom
a
1)
Management of
Unsatisfactory Smear
2) Management of
negative for
intraepithelial lesion or
malignancy (NILM)
smear
3) Management of
Abnormal Pap Smear
3.1 Squamous cell
carcinoma
3.1.1 Atypical cell
carcinoma
Action
CIN 1 / 2/ 3 completely
excised at hysterectomy
Women previously treated for
invasive gynecological
malignancy
Should be followed up by a
Gynecologist, preferably a
Gynecological Oncologist.
Management of
Abnormal Pap Smear and
CIN in Pregnancy
Colposcopic examination should be undertaken to
exclude invasive disease by a Colposcopist.
If a high grade lesion is suspected on colposcopy, a
biopsy is indicated to exclude possible invasive
disease. Cervical biopsy is safe in pregnancy.
If CIN 2 or 3 is present, colposcopic review should be
done in the second and third trimester to exclude
any possible progression to invasive disease.
Treatment of CIN should be deferred till at least 6
weeks postpartum, when the lesion should be
reassessed.
References
I. Guidelines for Pap Smear Screening
(Bethesda Classification 2001)
II. Obstetrics by Ten Teachers, 19th
Edition, Philip N. Baker
III. Obstetrics illustrated , 7th edition,
Kevin P.Hanretty
IV. Essentials of Obstetrics and
Gynecology, 5th edition, Hacker &
Moores